Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis

Bibliographische Detailangaben

Veröffentlicht in:	BJU international 2007-07, Vol.100 (s2), p.60-62
Hauptverfasser:	Koutsilieris, Michael, Dimopoulos, Theodore, Milathianakis, Constantine, Bogdanos, John, Karamanolakis, Dimitrios, Pissimissis, Nicholas, Halapas, Antonis, Lembessis, Peter, Papaioannou, Andreas, Sourla, Antigone
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Bone Neoplasms - drug therapy Bone Neoplasms - secondary Dexamethasone - therapeutic use Gonadotropin-Releasing Hormone - antagonists & inhibitors Humans Male Prostatic Neoplasms - drug therapy Somatostatin - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!